Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Nov;28(11):1525-9.
doi: 10.1007/s11606-013-2490-5. Epub 2013 May 17.

Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome

Affiliations
Case Reports

Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome

Stephanie A C Halvorson et al. J Gen Intern Med. 2013 Nov.

Abstract

Glucagonomas are slow-growing, rare pancreatic neuroendocrine tumors. They may present with paraneoplastic phenomena known together as the "glucagonoma syndrome." A hallmark sign of this syndrome is a rash known as necrolytic migratory erythema (NME). In this paper, the authors describe a patient with NME and other features of the glucagonoma syndrome. The diagnosis of this rare tumor requires an elevated serum glucagon level and imaging confirming a pancreatic tumor. Surgical and medical treatment options are reviewed. When detected early, a glucagonoma is surgically curable. It is therefore imperative that clinicians recognize the glucagonoma syndrome in order to make an accurate diagnosis and refer for treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Photo from dermatology clinic showing friable, erosive, erythematous plaques with crusting and scale on the lower back and gluteal region.
Figure 2.
Figure 2.
Photo from dermatology clinic showing papules along the corners of the mouth.
Figure 3.
Figure 3.
Photo on admission to the hospital showing acute left lower extremity cellulitis, as well as erythematous thin plaques with scale present on the right lower extremity and scattered hyperpigmented patches at the site of prior disease activity.
Figure 4.
Figure 4.
Photo on post-operative day 3 showing resolution of cellulitis, as well as evidence of healing of the NME (for example lateral aspect of the right shin and dorsum of right foot).

References

    1. Batcher E, Madaj P, Gianoukakis AG. Pancreatic neuroendocrine tumors. Endocr Res. 2011;36(1):35–43. doi: 10.3109/07435800.2010.525085. - DOI - PubMed
    1. Yao J, Eisner M, Leary C, et al. Population-based study of islet cell carcinoma. Ann Surg Oncol. 2007;14(12):3492–3500. doi: 10.1245/s10434-007-9566-6. - DOI - PMC - PubMed
    1. Eldor R, Glaser B, Fraenkel M, Doviner V, Salmon A, Gross DJ. Glucagonoma and the glucagonoma syndrome – cumulative experience with an elusive endocrine tumour. Clin Endocrinol. 2011;74(5):593–598. doi: 10.1111/j.1365-2265.2011.03967.x. - DOI - PubMed
    1. Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann Oncol. 2001;12(suppl 2):S69–S72. doi: 10.1093/annonc/12.suppl_2.S69. - DOI - PubMed
    1. Kindmark H, Sundin A, Granberg D, et al. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years. Med Oncol. 2007;24(3):330. doi: 10.1007/s12032-007-0011-2. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources